102 related articles for article (PubMed ID: 20940544)
1. Adrenal cortical imaging with I-131 NP-59 SPECT-CT.
Wong KK; Komissarova M; Avram AM; Fig LM; Gross MD
Clin Nucl Med; 2010 Nov; 35(11):865-9. PubMed ID: 20940544
[TBL] [Abstract][Full Text] [Related]
2. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
[TBL] [Abstract][Full Text] [Related]
3. [Cushing with transition from pituitary to adrenal origin. Study with SPECT scintigraphy of the adrenal cortex with norcholesterol-I 131 in a case].
Araya V; Jofré J; Hidalgo P; Massardo T; Amat J; Pumarino H
Rev Med Chil; 1998 Sep; 126(9):1103-7. PubMed ID: 9922515
[TBL] [Abstract][Full Text] [Related]
4. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
6. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas.
Imperiale A; Olianti C; Mannelli M; La Cava G; Pupi A
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):287-96. PubMed ID: 16172575
[TBL] [Abstract][Full Text] [Related]
7. SPECT/CT characterization of oral activity on radioiodine scintigraphy.
Savas H; Wong KK; Saglik B; Hubers D; Ackermann RJ; Avram AM
J Clin Endocrinol Metab; 2013 Nov; 98(11):4410-6. PubMed ID: 24001748
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan.
Wu MH; Liu FH; Lin KJ; Sun JH; Chen ST
Nucl Med Commun; 2019 Jun; 40(6):568-575. PubMed ID: 30694876
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical SPECT using iodine-131 NP-59.
Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
[TBL] [Abstract][Full Text] [Related]
10. Value of bowel preparation in adrenocortical scintigraphy with NP-59.
Shapiro B; Nakajo M; Gross MD; Freitas J; Copp J; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):732-4. PubMed ID: 6875684
[TBL] [Abstract][Full Text] [Related]
11. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
[TBL] [Abstract][Full Text] [Related]
12. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
[TBL] [Abstract][Full Text] [Related]
13. The relationship of I-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal cortical uptake to indices of androgen secretion in women with hyperandrogenism.
Gross MD; Shapiro B; Freitas JE; Ayers J; Swanson DP; Woodbury MC; Schteingart DE; Beierwaltes WH
Clin Nucl Med; 1984 May; 9(5):264-70. PubMed ID: 6235079
[TBL] [Abstract][Full Text] [Related]
14. Enterohepatic circulation and distribution of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59).
Lynn MD; Gross MD; Shapiro B
Nucl Med Commun; 1986 Aug; 7(8):625-30. PubMed ID: 3774259
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of iodine-131 6beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism.
Nocaudie-Calzada M; Huglo D; Lambert M; Ernst O; Proye C; Wemeau JL; Marchandise X
Eur J Nucl Med; 1999 Oct; 26(10):1326-32. PubMed ID: 10541832
[TBL] [Abstract][Full Text] [Related]
16. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
Gross MD; Shapiro B; Freitas JE
J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
[TBL] [Abstract][Full Text] [Related]
17. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma.
Ruíz Hernández G; Pallarés FJ; Bartual AR; Tenes Rodrigo S; Ampudia-Blasco FJ; de Avila y Avalos CR
Nuklearmedizin; 1998 Jun; 37(4):141-5. PubMed ID: 9650214
[TBL] [Abstract][Full Text] [Related]
19. The influence of hypercholesterolaemia on the adrenal uptake and metabolic handling of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59).
Lynn MD; Gross MD; Shapiro B; Bassett D
Nucl Med Commun; 1986 Aug; 7(8):631-7. PubMed ID: 3774260
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Fukuoka M; Taki J; Mochizuki T; Kinuya S
Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
